Theriva Biologics, Inc. Profile Avatar - Palmy Investing

Theriva Biologics, Inc.

Theriva Biologics Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in …

Biotechnology
US, Rockville [HQ]

Investor Relations

Could not find a transcript